СÀ¶ÊÓƵ

Skip to content

Aurora Cannabis revenues rise in Q2, led by strength in medical cannabis sales

EDMONTON — Aurora Cannabis Inc. says it earned $256,000 in the second quarter, up from a loss a year earlier of $45.5 million. The Edmonton-based cannabis company says net revenue for the quarter was $63.4 million, up from $48.
20231109171120-654d5b753241132efea5c91ejpeg
Cannabis seedlings are shown at an Aurora Cannabis grow facility in Montreal on Friday, Nov. 24, 2017.THE CANADIAN PRESS/Ryan Remiorz

EDMONTON — Aurora Cannabis Inc. says it earned $256,000 in the second quarter, up from a loss a year earlier of $45.5 million. 

The Edmonton-based cannabis company says net revenue for the quarter was $63.4 million, up from $48.6 million during the same quarter a year earlier.

The company attributed the increase to growth in its global medical cannabis business and quarterly revenue in its plant propagation business. 

CEO Miguel Martin says it was the company's strongest fiscal year to date. 

He says Aurora is experiencing the benefits of diversification across its cannabis and non-cannabis platforms. 

The company's net revenue from medical cannabis rose 42 per cent from a year earlier, while revenues from consumer cannabis were slightly lower. 

This report by The Canadian Press was first published Nov. 9, 2023.

Companies in this story: (TSX:ACB)

The Canadian Press

push icon
Be the first to read breaking stories. Enable push notifications on your device. Disable anytime.
No thanks